VivoSeq
Other

Head and Neck

0

Pipeline Programs↗

7

Active Trials↗

5

Companies Involved↗

Head and Neck is an early-stage landscape with 0 programs across 5 companies. The most active players are AstraZeneca, Hellenic Cooperative Oncology Group, Sanofi.

Intelligence

Pipeline Metrics

Competitive Density

22/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

80/100

Attrition Rate

10/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

AstraZeneca logo

AstraZeneca

0 programs

PreclinicalH

Hellenic Cooperative Oncology Group

0 programs

PreclinicalSanofi logo

Sanofi

0 programs

PreclinicalA

Alume Biosciences, Inc.

0 programs

PreclinicalCSPC ZhongQi Pharmaceutical Technology Co., Ltd. logo

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

31

clinical trials

Completed12 · 39%
Unknown status9 · 29%
Active, not recruiting3 · 10%
Recruiting3 · 10%
Terminated2 · 6%
Withdrawn1 · 3%
Other1 · 3%

Clinical Trials

Trial Activity

31 trials

EMG-Based Evaluation of Occlusal Splint and Masseter Botox Effects on Head and Neck Muscles
Recruiting·IIstanbul University·Phase 4·NCT07082972·56 enrolled
Evaluating rhPDGF-BB-Enhanced Wound Matrix for Head and Neck Reconstruction
Recruiting·VVanderbilt University Medical Center·Phase 2·NCT06634030·40 enrolled
Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer
Recruiting·SScancell Ltd·Phase 1/2·NCT05329532·168 enrolled
Cough, Expiratory Training, and Chronic Aspiration After Head and Neck Radiotherapy
Active, not recruiting·MM.D. Anderson Cancer Center·N/A·NCT02662907·175 enrolled
A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck
Active, not recruiting·GGroupe Oncologie Radiotherapie Tete et Cou·Phase 3·NCT03576417·680 enrolled
Imaging With a PET Agent for Detection of Cancers of the Head and Neck
Active, not recruiting·MMemorial Sloan Kettering Cancer Center·Phase 1/2·NCT03631017·12 enrolled
CLASSIFY-OMM: Multicenter Rare Disease Cohort for T-Stage Reclassification and Molecular Subtyping-Based Precision Therapy in Oral Mucosal Melanoma
Not yet recruiting·SShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University·N/A·NCT07662694·1,100 enrolled
Perioperative Gabapentin Use In Head And Neck Mucosal Surgery Patients
Completed·WWashington University School of Medicine·Phase 4·NCT02926573·123 enrolled
Effect of Remifentanil on the Recovery Profile After Prolonged Head and Neck Surgery
Completed·SSingapore General Hospital·N/A·NCT02416752·222 enrolled
Preoperative Administration of Olaparib With Cisplatin or With Durvalumab or Alone or no Tratment in Patients Who Are Candidates for Surgery of Carcinoma of the Head and Neck.
Completed·HHellenic Cooperative Oncology Group·Phase 2·NCT02882308·41 enrolled
Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies
Completed·UUniversity of Louisville·Phase 2·NCT00266279·17 enrolled
Impact of Applying a Bandage Skin Hydrogel on the Pains of the Head and Neck in Patients With Cancer of Head and Neck Treated With Radiotherapy
Completed·CCentre Francois Baclesse·Phase 3·NCT01520701·125 enrolled
Topical Anaesthesia in Cutaneous Head and Neck Surgery
Completed·UUniversity Hospital Waterford·N/A·NCT06274905·124 enrolled
Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)
Completed·AstraZeneca logoAstraZeneca·Phase 3·NCT00206219·477 enrolled
Cetuximab and Lenalidomide in Head and Neck
Completed·UUniversity of Chicago·Phase 2·NCT01133665·42 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)